Visual Abstract (IMAGE)

Michigan Medicine - University of Michigan

Visual Abstract

Caption

Compared to breast cancer patients with a negative test result, those with a BRCA1/2 variant may not receive guideline-concordant treatment.

Credit

University of Michigan Rogel Cancer Center

Usage Restrictions

for use in stories about this research

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.